TrialThe Journal of urology2008

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.

M R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.